Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Paediatric anticoagulation guidelines.

Schapkaitz E, Sherman GG, Jacobson BF, Haas S, Buller HR, Davies V, Diar H, Peters M, Shuttleworth M, Velaphi S; South African Society of Thombosis and Haemostasis.

S Afr Med J. 2012 Feb 23;102(3 Pt 1):171-5.

PMID:
22380915
2.

Venous thromboembolism--prophylactic and therapeutic practice guideline.

Jacobson BF, Louw S, Mer M, Haas S, Büller HR, Abdul-Carim AT, Adler D, Beaton A, de Jong PR, van der Jagt D, Levy B, Pearl J, Schapkaitz E, Wessels P; Southern African Society of Thrombosis and Haemostasis.

S Afr Med J. 2009 Jun;99(6):467-8, 470-3.

PMID:
19736851
3.

Venous thromboembolism: prophylactic and therapeutic practice guideline.

Jacobson BF, Louw S, Büller H, Mer M, de Jong PR, Rowji P, Schapkaitz E, Adler D, Beeton A, Hsu HC, Wessels P, Haas S; South African Society of Thrombosis and Haemostasis.

S Afr Med J. 2013 Feb 15;103(4 Pt 2):261-7. doi: 10.7196/samj.6706.

PMID:
23547704
4.

Updated guidelines on outpatient anticoagulation.

Wigle P, Hein B, Bloomfield HE, Tubb M, Doherty M.

Am Fam Physician. 2013 Apr 15;87(8):556-66.

5.

Recommendations for the anticoagulation of pregnant patients with mechanical heart valves.

Schapkaitz E, Jacobson BF, Manga P, Chitsike RS, Benade E, Jackson S, Haas S, Buller HR; South African Society of Thrombosis and Haemostasis.

S Afr Med J. 2015 Sep 14;105(9):733-8. doi: 10.7196/SAMJnew.7928.

PMID:
26428968
6.

Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.

Raskob G, Büller H, Prins M, Segers A, Shi M, Schwocho L, van Kranen R, Mercuri M; Hokusai-VTE Investigators.

J Thromb Haemost. 2013 Jul;11(7):1287-94. doi: 10.1111/jth.12230.

7.

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.

Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM; Warfarin Reversal Consensus Group.

Med J Aust. 2004 Nov 1;181(9):492-7. Review. Erratum in: Med J Aust. 2005 Jan 3;182(1):48.

PMID:
15516194
8.

Guideline on the investigation, management and prevention of venous thrombosis in children.

Chalmers E, Ganesen V, Liesner R, Maroo S, Nokes T, Saunders D, Williams M; British Committee for Standards in Haematology.

Br J Haematol. 2011 Jul;154(2):196-207. doi: 10.1111/j.1365-2141.2010.08543.x. Epub 2011 May 20. Review.

PMID:
21595646
9.

[Advantages and disadvantages of warfarin and pradaxa therapy for venous thromboembolism].

Sukovatykh BS, Belikov LN, Savchuk OF, Sukovatykh MB.

Vestn Khir Im I I Grek. 2014;173(4):87-91. Russian.

PMID:
25552114
10.

Guidelines on oral anticoagulation with warfarin - fourth edition.

Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, Kitchen S, Makris M; British Committee for Standards in Haematology.

Br J Haematol. 2011 Aug;154(3):311-24. doi: 10.1111/j.1365-2141.2011.08753.x. Epub 2011 Jun 14. Review. No abstract available.

PMID:
21671894
11.

Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.

Deitelzweig SB, Lin J, Kreilick C, Hussein M, Battleman D.

Adv Ther. 2010 Sep;27(9):623-33. doi: 10.1007/s12325-010-0056-z. Epub 2010 Jul 30.

PMID:
20680533
12.

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.

Liew A, Eikelboom JW, O'Donnell M, Hart RG.

Can J Cardiol. 2013 Jul;29(7 Suppl):S34-44. doi: 10.1016/j.cjca.2013.04.013. Review.

PMID:
23790596
13.

Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.

Wong CS, Batchelor K, Bua J, Newall F.

Thromb Res. 2011 Oct;128(4):331-4. doi: 10.1016/j.thromres.2011.04.020. Epub 2011 May 26.

PMID:
21620442
14.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR.

J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. Review.

15.

Guideline for prophylactic anticoagulation.

Southern African Society of Thrombosis and Haemostasis.

S Afr Med J. 2004 Aug;94(8 Pt 2):691-5.

16.

Aspects of anticoagulation in children.

Payne JH.

Br J Haematol. 2010 Aug;150(3):259-77. doi: 10.1111/j.1365-2141.2010.08225.x. Epub 2010 May 26. Review.

PMID:
20528873
17.

Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?

Le Gal G, Carrier M, Tierney S, Majeed H, Rodger M, Wells PS.

J Thromb Haemost. 2010 Jan;8(1):90-4. doi: 10.1111/j.1538-7836.2009.03676.x. Epub 2009 Oct 30.

18.

Practice guidelines for reversal of new and old anticoagulants.

Hartman SK, Teruya J.

Dis Mon. 2012 Aug;58(8):448-61. doi: 10.1016/j.disamonth.2012.04.003. Review. No abstract available.

PMID:
22818559
19.

Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.

Lemos Silva R, Carvalho de Sousa J, Calisto C, Braz Nogueira JM, Ravara L.

Rev Port Cardiol. 2007 Jul-Aug;26(7-8):769-88. Review. English, Portuguese.

20.

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.

Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, Fernández-Capitán C, Ruiz-Giménez N, Madridano O, Sillero PL; PGX-ACE Spanish Investigators Group.

Trials. 2012 Dec 13;13:239. doi: 10.1186/1745-6215-13-239.

Items per page

Supplemental Content

Write to the Help Desk